Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vacca

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosisA Prinster, M Quarantelli, R Lanzillo, et al.
Acta Neurologica Scandinavica|November 24, 2011
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective studyR Lanzillo, M Quarantelli, S Bonavita, et al.
Brain Research. Brain Research Protocols|August 28, 2001
Procedure of bidirectional selective outbreeding for production of two rat lines differing in sensitivity to the sedative/hypnotic effect of gamma-hydroxybutyric acidC Lobina, G Colombo, G Brunetti, et al.
Fitoterapia|August 10, 2000
Potential use of medicinal plants in the treatment of alcoholismM A Carai, R Agabio, E Bombardelli, et al.
European Journal of Neurology|August 26, 2006
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosisG Coppola, R Lanzillo, C Florio, et al.
European Journal of Neurology|May 19, 2011
Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patientsR Lanzillo, C Di Somma, M Quarantelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 11, 2011
Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapyR Lanzillo, G Orefice, A Prinster, et al.
Neuroimage|October 6, 2005
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry studyA Prinster, M Quarantelli, G Orefice, et al.
European Journal of Pharmacology|November 2, 2001
Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acidM A Carai, G Colombo, G Brunetti, et al.
Brain Research|May 30, 2001
Selective breeding of two rat lines differing in sensitivity to GHB and baclofenG Colombo, C Lobina, R Agabio, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosisA Prinster, M Quarantelli, R Lanzillo, et al.
Acta Neurologica Scandinavica|November 24, 2011
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective studyR Lanzillo, M Quarantelli, S Bonavita, et al.
Brain Research. Brain Research Protocols|August 28, 2001
Procedure of bidirectional selective outbreeding for production of two rat lines differing in sensitivity to the sedative/hypnotic effect of gamma-hydroxybutyric acidC Lobina, G Colombo, G Brunetti, et al.
Fitoterapia|August 10, 2000
Potential use of medicinal plants in the treatment of alcoholismM A Carai, R Agabio, E Bombardelli, et al.
European Journal of Neurology|August 26, 2006
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosisG Coppola, R Lanzillo, C Florio, et al.
European Journal of Neurology|May 19, 2011
Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patientsR Lanzillo, C Di Somma, M Quarantelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 11, 2011
Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapyR Lanzillo, G Orefice, A Prinster, et al.
Neuroimage|October 6, 2005
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry studyA Prinster, M Quarantelli, G Orefice, et al.
European Journal of Pharmacology|November 2, 2001
Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acidM A Carai, G Colombo, G Brunetti, et al.
Brain Research|May 30, 2001
Selective breeding of two rat lines differing in sensitivity to GHB and baclofenG Colombo, C Lobina, R Agabio, et al.
Pageof 16